Benzinga
Why Twist Bioscience Stock Is Tumbling Today
Twist Bioscience Corp (NASDAQ: TWST) reported Q2 FY23 sales of $60.2 million, up 25%, beating the consensus of $56.6 million. The company shipped approximately 152,000 genes during the quarter to 2,100 customers, compared to 124,000 genes to about 2,000 customers during the year-ago quarter. For Q2, the company reported an EPS loss of $(1.04), compared to $(1.13) a year ago, beating the consensus of $(1.12). Twist announced to reduce its workforce by approximately 270 employees, or about 25%. Ma
